印度的新冠疫情后果与重症护理
Aftermath of COVID-19 and Critical Care in India.
作者信息
Panda Rajesh, Hirolli Divya, Baidya Dalim K
机构信息
Department of Anesthesiology and Critical Care, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Department of Anesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciences, New Delhi, India.
出版信息
Indian J Crit Care Med. 2021 Oct;25(10):1173-1175. doi: 10.5005/jp-journals-10071-23987.
The coronavirus disease-2019 (COVID-19) pandemic had overwhelmed the healthcare system and forced many patients to be treated at home with oxygen, antibiotics, and steroids, particularly during the second wave. There was increased misuse of antimicrobials in hospitals as well as unguarded self-prescription of these medications among the common people. We are likely to see an increase in the incidence of antimicrobial resistance (AMR), change in the susceptibility pattern of the organisms causing community-acquired infections, and an increase in opportunistic bacterial, tubercular, viral, and fungal infections. Panda R, Hirolli D, Baidya DK. Aftermath of COVID-19 and Critical Care in India. Indian J Crit Care Med 2021; 25(10):1173-1175.
2019年冠状病毒病（COVID-19）大流行使医疗系统不堪重负，迫使许多患者在家中使用氧气、抗生素和类固醇进行治疗，尤其是在第二波疫情期间。医院对抗生素的滥用有所增加，普通民众也存在这些药物的无防护自我用药情况。我们可能会看到抗菌药物耐药性（AMR）的发生率上升、引起社区获得性感染的病原体药敏模式发生变化，以及机会性细菌、结核、病毒和真菌感染增加。Panda R、Hirolli D、Baidya DK。印度COVID-19的后果与重症监护。《印度重症监护医学杂志》2021年；25(10):1173 - 1175。
Zotero 插件